Skip to content

Progyny PGNY Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

CVS Health logo
CVS HealthCVS
UnitedHealth Group logo
UnitedHealth GroupUNH
Natera, Inc. logo
Natera, Inc.NTRA
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
Pediatrix Medical Group logo
Pediatrix Medical GroupMD

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's software and technology licenses, net?
Progyny (PGNY) reported software and technology licenses, net of $17.87M in Q1 2026.
How has Progyny's software and technology licenses, net changed year-over-year?
Progyny's software and technology licenses, net increased by 109.0% year-over-year, from $8.55M to $17.87M.
What is the long-term trend for Progyny's software and technology licenses, net?
Over 5 years (2020 to 2025), Progyny's software and technology licenses, net has grown at a 95.9% compound annual growth rate (CAGR), from $573K to $16.54M.